These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16876120

  • 1. Sp1 mediates repression of the resistin gene by PPARgamma agonists in 3T3-L1 adipocytes.
    Chung SS, Choi HH, Cho YM, Lee HK, Park KS.
    Biochem Biophys Res Commun; 2006 Sep 15; 348(1):253-8. PubMed ID: 16876120
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X, Kanjanabuch T, Mao SL, Hao CM, Tang YW, Declerck PJ, Hasty AH, Wasserman DH, Fogo AB, Ma LJ.
    Am J Physiol Endocrinol Metab; 2006 Jan 15; 290(1):E103-E113. PubMed ID: 16144810
    [Abstract] [Full Text] [Related]

  • 3. Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1.
    Chung SS, Kim JH, Park HS, Choi HH, Lee KW, Cho YM, Lee HK, Park KS.
    Biochem Biophys Res Commun; 2008 Aug 08; 372(4):713-8. PubMed ID: 18513490
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes.
    Bonofiglio D, Santoro A, Martello E, Vizza D, Rovito D, Cappello AR, Barone I, Giordano C, Panza S, Catalano S, Iacobazzi V, Dolce V, Andò S.
    Biochim Biophys Acta; 2013 Jun 08; 1831(6):1027-36. PubMed ID: 23370576
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
    Bonofiglio D, Qi H, Gabriele S, Catalano S, Aquila S, Belmonte M, Andò S.
    Endocr Relat Cancer; 2008 Jun 08; 15(2):545-57. PubMed ID: 18509005
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor gamma agonists inhibit adipocyte expression of alpha1-acid glycoprotein.
    Castriota G, Thompson GM, Lin Y, Scherer PE, Moller DE, Berger JP.
    Cell Biol Int; 2007 Jun 08; 31(6):586-91. PubMed ID: 17240171
    [Abstract] [Full Text] [Related]

  • 7. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
    Xiao Y, Yuan T, Yao W, Liao K.
    FEBS J; 2010 Feb 08; 277(3):687-96. PubMed ID: 20050918
    [Abstract] [Full Text] [Related]

  • 8. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T, Kimura C, Oe T, Takata Y, Sakuma H, Aramori I, Mutoh S.
    J Pharmacol Exp Ther; 2006 Aug 08; 318(2):863-71. PubMed ID: 16682454
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
    Mughal RS, Warburton P, O'Regan DJ, Ball SG, Turner NA, Porter KE.
    Clin Exp Pharmacol Physiol; 2009 May 08; 36(5-6):478-86. PubMed ID: 19673929
    [Abstract] [Full Text] [Related]

  • 10. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS, Cha BY, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT.
    Life Sci; 2009 Jun 19; 84(25-26):908-14. PubMed ID: 19376135
    [Abstract] [Full Text] [Related]

  • 11. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH, McNamara LA, Wu MS, Muise ES, Tan Y, Wood HB, Meinke PT, Thompson JR, Doebber TW, Berger JP, McCann ME.
    Eur J Pharmacol; 2008 Apr 14; 584(1):192-201. PubMed ID: 18346728
    [Abstract] [Full Text] [Related]

  • 12. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
    Kong J, Li YC.
    Am J Physiol Endocrinol Metab; 2006 May 14; 290(5):E916-24. PubMed ID: 16368784
    [Abstract] [Full Text] [Related]

  • 13. Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.
    Petrovic V, Costa RH, Lau LF, Raychaudhuri P, Tyner AL.
    Cancer Biol Ther; 2010 Jun 15; 9(12):1008-16. PubMed ID: 20372080
    [Abstract] [Full Text] [Related]

  • 14. Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins.
    Tomaru T, Steger DJ, Lefterova MI, Schupp M, Lazar MA.
    J Biol Chem; 2009 Mar 06; 284(10):6116-25. PubMed ID: 19126543
    [Abstract] [Full Text] [Related]

  • 15. A high-capacity assay for PPARgamma ligand regulation of endogenous aP2 expression in 3T3-L1 cells.
    Thompson GM, Trainor D, Biswas C, LaCerte C, Berger JP, Kelly LJ.
    Anal Biochem; 2004 Jul 01; 330(1):21-8. PubMed ID: 15183757
    [Abstract] [Full Text] [Related]

  • 16. The effect of PPARgamma ligands on the adipose tissue in insulin resistance.
    Hammarstedt A, Andersson CX, Rotter Sopasakis V, Smith U.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jul 01; 73(1):65-75. PubMed ID: 15936183
    [Abstract] [Full Text] [Related]

  • 17. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling.
    Moyers JS, Shiyanova TL, Mehrbod F, Dunbar JD, Noblitt TW, Otto KA, Reifel-Miller A, Kharitonenkov A.
    J Cell Physiol; 2007 Jan 01; 210(1):1-6. PubMed ID: 17063460
    [Abstract] [Full Text] [Related]

  • 18. Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways.
    Barth N, Langmann T, Schölmerich J, Schmitz G, Schäffler A.
    Diabetologia; 2002 Oct 01; 45(10):1425-33. PubMed ID: 12378384
    [Abstract] [Full Text] [Related]

  • 19. Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands.
    Rival Y, Stennevin A, Puech L, Rouquette A, Cathala C, Lestienne F, Dupont-Passelaigue E, Patoiseau JF, Wurch T, Junquéro D.
    J Pharmacol Exp Ther; 2004 Nov 01; 311(2):467-75. PubMed ID: 15273253
    [Abstract] [Full Text] [Related]

  • 20. c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes.
    Kim KY, Kim JK, Jeon JH, Yoon SR, Choi I, Yang Y.
    Biochem Biophys Res Commun; 2005 Feb 11; 327(2):460-7. PubMed ID: 15629137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.